Trial Profile
Clinical Trials Insight: 700034471
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 12 Jun 2008
Price :
$35
*
At a glance
- Drugs Oxybutynin (Primary)
- Indications Overactive bladder
- Focus Pharmacokinetics
- Sponsors Actavis Inc
- 12 Jun 2008 New trial record.